19
Participants
Start Date
January 16, 2018
Primary Completion Date
November 6, 2020
Study Completion Date
November 6, 2020
Trans Sodium Crocetinate plus SOC
Trans Sodium Crocetinate (TSC) plus the Standard of Care (SOC): SOC composed of radiation and temozolomide for 6 weeks followed by 4 weeks of rest followed by six (6) 28-day cycles of temozolomide
Standard of Care (SOC)
Standard of Care (SOC): SOC composed of radiation and temozolomide for 6 weeks followed by 4 weeks of rest followed by six (6) 28-day cycles of temozolomide
Mount Sinai Hospital, New York
North Shore University Hospital, Manhasset
Scott Lindhorst, M.D., Charleston
Piedmont Cancer, Atlanta
John B. Amos Cancer Center, Columbus
Abbott Northwestern Hospital, Minneapolis
Neuro Oncology Associates, Dallas
UNM Comprehensive Cancer Center, Albuquerque
John Wayne Cancer Institute @ Providence Saint John's Health Center, Santa Monica
University of California, Irvine
Scott Peak, M.D., Redwood City
Providence Portland Medical Center, Portland
John Theurer Cancer Center, Hackensack
Lead Sponsor
Diffusion Pharmaceuticals Inc
INDUSTRY